Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

We're back with the second half of our Phase 5 ranking, and it's now time to see how the likes of Deadpool & Wolverine, Your ...

Boss fights need to be climactic, difficult, and most importantly, memorable. However, here are some fights that didn't tick ...

Viking Therapeutics's obesity/diabetes candidates and strong financials position it for success. Read here for an investment ...

Nvision Development, which will manage the operation of the student housing community, is set to break ground on the first ...

More than half of the first phase of the 3.5 GW solar and 4.5 GWh battery storage MTerra Solar project in the Philippines is ...

While generational change is inevitable, maturity is a choice, and the most enduring Family Offices are those that ...

Marvel’s Phase 5 is shaping up to be a tough chapter for the MCU. Not only has it left fans with a lot of unanswered ...

Rochester’s $65M outdoor sports complex moves forward with city council approval; construction begins this fall, phase two to ...

An effort to close the project's funding gap died in the Oregon legislature two weeks ago, and now the Trump bill appears to ...

This paper presents a Finite Control Set Model Predictive Control (FCS-MPC) algorithm for the three-phase 5-level multiplexed converter (3ϕ5L MLMXC). The 3ϕ5L MLMXC comprises two Flying Capacitors (FC ...

In recent years, the FDA has approved three complement inhibitors for gMG -- eculizumab (Soliris), ravulizumab (Ultomiris), ...